All posts by imreal

Shriners Children’s Announces Inaugural Annual Campaign 31 Days to Amaze


News Image

“We look forward to giving the corporate community a platform to support the impact we make for children while also helping to drive additional customers for them,” said Sullivan.

Shriners Children’s has announced a new fundraising campaign, 31 Days to Amaze, launching nationwide in October 2022.

The 31 Days to Amaze campaign is a month-long incentive program that seeks to unite businesses and the community to help support the mission of Shriners Children’s. Shriners Children’s is inviting business owners and operators to become a 31 Days to Amaze partner and take advantage of the positive visibility that comes with that commitment. All funds donated by the supporting business partners will help ensure that Shriners Children’s continues to provide children around the world with the Most Amazing Care Anywhere.

“We are extremely excited to announce this one-of-kind opportunity for our business supporters,” said Stuart Sullivan, Chief Development Officer of Shriners Children’s. “We look forward to giving the corporate community a platform to support the impact we make for children while also helping to drive additional customers for them.”

Shriners Children’s is a special, one-of-a-kind healthcare system with a reputation for finding answers, and giving families hope for their child’s future. Since opening their first hospital in 1922, Shriners Children’s has made it their mission to improve the lives of children, regardless of a families’ ability to pay or insurance status. Over the last century, Shriners Children’s has treated more than 1.5 million children, and that commitment to change lives hasn’t changed, but has only strengthened.

“It was our goal from the beginning to build a program that is very easy for all to participate,” said Ryan West, Director of Strategic Partnerships of Shriners Children’s. “We feel we have developed a process that is very simple for businesses to register and our supporters to find and patronize those businesses.”

Those interested in partnering with Shriners Children’s and joining our efforts of changing lives through innovative pediatric specialty care, world-class research, and outstanding medical education should visit 31daystoamaze.org to learn more. We also encourage you to visit that site to nominate a potential business partner.

About Shriners Children’s

Shriners Children’s is changing lives every day through innovative pediatric specialty care, world-class research and outstanding medical education. Our multiple locations in the United States, Canada and Mexico provide advanced care for children with orthopedic conditions, burns, spinal cord injuries, and cleft lip and palate. All care is provided regardless of the families’ ability to pay. Shriners Children’s has treated more than 1.5 million children from more than 170 countries over the last 100 years.

For more information on the care provided by Shriners Children’s, go to shrinerschildrens.org.

Shriners Hospitals for Children is a 501(c)(3) nonprofit organization and relies on the generosity of donors. All donations are tax deductible to the fullest extent permitted by law.

Share article on social media or email:

AmSpa Releases 2022 Medical Spa State of the Industry Report


“While COVID certainly had an impact, the data shows that this industry has continued its pattern of explosive growth with no signs of slowing down.” says AmSpa CEO, Alex R. Thiersch, JD.

“We are so excited to release AmSpa’s long-awaited State of the Industry Report,” says AmSpa CEO, Alex R. Thiersch, JD. “This report is the only one of its kind in the industry, focusing exclusively on the business aspects of non-surgical aesthetics in the United States. There is so much to be excited about in this data—I’ve devoured the report several times and always come away with something new. What’s most exciting is that it’s clear we are still on the ground floor of a nascent industry.”

From August 2021 to March 2022, AmSpa, along with partner Gordian Solutions Group (GSG), conducted an online survey of medical spa owners, and that information makes up the bulk of the information in the report. Additionally, AmSpa members and subject matter experts were interviewed to provide even deeper insights into the topics, which include:


  • Demographics for medical spa professionals and patients;
  • Medical spa ownership structure;
  • Business statistics and benchmarks;
  • Most profitable procedures;
  • Patient spending habits;
  • And much more.

“The past two years in the medical aesthetics industry have been the most interesting and impactful in its history. Between the incredible growth and popularity of the industry and its treatments and the impact (both positive and negative) of COVID-19, medical aesthetics has experienced a ‘baptism by fire’ maturation, and AmSpa’s newest State of the Industry Report delves into the details of all of it,” AmSpa’s COO, Cathy Christensen, explains. “AmSpa, who once again partnered with GSG to gather this data, is so excited to share the one-of-a-kind insight into the evolution of the medical aesthetics industry.”

Prior to the COVID-19 pandemic, the medical aesthetic industry was growing at a remarkable rate. The 2022 Medical Spa State of the Industry Report outlines the impact the pandemic has had on the present and future of medical aesthetics, helping readers to understand where their businesses are in relation to the rest of the industry and how they can improve their bottom line.

“One thing we continue to see is explosive growth throughout the industry,” says Thiersch. “While COVID certainly had an impact, the data shows that this industry has continued its pattern of explosive growth with no signs of slowing down. The COVID impact was merely a speedbump—following a brief dip, the industry not only rebounded but has now exceeded all projections we made prior to the pandemic. The next five to 10 years should be really exciting.”

An executive summary of the 2022 Medical Spa State of the Industry Report is available for free to non-members and AmSpa Basic Members, and the full report is available for free to AmSpa Plus Members (it can be purchased by Basic and non-members). Click here to download or purchase the full report or click here to become an AmSpa Plus member.

—

About the American Med Spa Association (AmSpa)

The American Med Spa Association (AmSpa) provides business, legal, and clinical training and resources to medical spas and aesthetic practices throughout the country. AmSpa’s events—including Medical Spa & Aesthetic Boot Camps, Academy for Injection Anatomy trainings and Medical Spa Show—provide business and legal best-practices to anyone entering the medical spa space or looking to improve their existing practice. AmSpa Members receive access to legal summaries of laws governing medical spas in their state, discounts, a robust and growing webinar library, and many other benefits. For more information visit http://www.americanmedspa.org, call 312-981-0993, or email info@americanmedspa.org.

Share article on social media or email:

Aesthetics Biomedical® Hires Two New Executives to Join the Company’s Leadership Team to Fuel Growth Trajectory


“I’m honored to be joining an organization about to reignite aesthetics with Vivace Ultra™ and SoME® PRP Skincare,” says Derek Harmon.

Aesthetics Biomedical® Inc. (ABM), in its ongoing efforts to meet the increasing demand for its revolutionary aesthetic products and distribution growth, is continuing to build its executive team recruiting top industry experts Derek Harmon as Vice President of U.S. Sales and Don Selvey, NMD, MS as Vice President of Regulatory respectively. Mr. Harmon and Dr. Selvey will play pivotal roles in the company’s expansion and national distribution of current products including the legacy Vivace® Microneedle RF treatment and device, SoME® PRP Skincare and focus on the new era of energy-based technology with Vivace Ultra™, with expected FDA Clearance, is expected to roll-out via limited commercial release in the fall to top tier plastic surgeons, dermatologists, and medical aesthetic practitioners across the country.

“I’m honored to be joining an organization about to reignite aesthetics with Vivace Ultra™ and SoME® PRP Skincare,” says Derek Harmon. “I’m impressed with what the team has created that uniquely positions ABM as a leader in this industry”, he continued. “After over two decades of experience encompassing a deep understanding of the aesthetics market and the needs of patients and providers alike, I could not be more thrilled to lead U.S. Sales, Practice Development, and Clinical teams to new heights with our portfolio.”

Mr. Harmon brings an award-winning, 20+ year career of industry expertise, results, and leadership to the ABM Executive Team. A seasoned, results-oriented Sales & Marketing Executive with a background focused on aesthetics, medical devices, capital equipment, pharmaceutical and healthcare, Derek most recently served as Director of Surgical Sales at Cynosure. He co-created their surgical division and implemented MyEllevate®, their successful, minimally invasive surgical technology. Prior to Cynosure, Derek was the Director of Business Development for Fresenius Medical Care and responsible for the growth of $400M in treatment revenue, through strategic M&A, joint ventures, and real-estate development of clinics. Derek simultaneously led the company’s telemedicine rollout during the COVID-19 pandemic to keep physicians, clinical teams, and patients safe during an unprecedented time.

Previously, he also spent nearly a decade at Allergan, holding various leadership roles in sales, marketing and practice development, building aesthetic markets for Botox® Cosmetic, Juvederm® XC, Kybella®, Voluma®, Latisse®, and the Allē℠ Patient Loyalty Program. Derek also held positions at Pfizer-Wyeth and Merck & Co. Inc. He currently serves as a Board Member for RealSelf’s Industry Insiders.

Dr. Don Selvey will oversee Regulatory Affairs and Quality Assurance for Aesthetics Biomedical® Inc., bringing a combination of more than 30 years of clinical practice and industry experience in regulatory and clinical activity with medical device and pharmaceutical companies. Dr. Selvey has worked with medical device designers and manufacturers to produce novel devices such as external and implantable drug delivery systems, the original continuous glucose monitoring system, permanently implanted biomaterials for both bone and soft tissues, orthopedic implants and aesthetic dermal fillers and neuromodulators.

“I am very pleased to have joined Aesthetics Biomedical® Inc. working across compliance, quality and regulatory affairs departments for such an exceptional portfolio of advanced devices. With such a strong leadership team, innovative technologies in their Microneedle RadioFrequency device and breadth of practice relationships, I am excited for this next chapter with a company poised for even greater accomplishments and successes ahead.,” says Dr. Selvey.

Aesthetics Biomedical®, led by Founder & Chief Executive Officer, MaryAnn Guerra, achieved its initial success with Vivace® Microneedle RF and Vivace Experience® in the US, the most well-known RF microneedling treatment device in the industry, with exceptional technology and patient outcome. Aesthetics Biomedical® is now poised for industry leadership in the advanced aesthetics space with an expanded, elevated and forward-thinking management team and the latest unique multi-modality device to deliver the most advances in bespoke aesthetics and beauty.

ABOUT AESTHETICS BIOMEDICAL®: Aesthetics Biomedical® Inc., headquartered in Phoenix, Ariz., is committed to the development and distribution of novel aesthetic devices, products, and services in the global market. Aesthetics Biomedical’s innovation center is a leader in breakthrough technologies and combination therapies for its clients, physician network and the aesthetic arena, creating novel patient treatment experiences that benefit from ongoing research, approved clinical indications for use, as well as a personalized approach designed for consumer benefit. For more information, please visit AestheticsBiomedical.com. IGTwitterLinkedinFacebook

Share article on social media or email:



MedReview Achieves HITRUST® Authorized External Assessor Designation


News Image

“As a leading healthcare review organization serving payors from coast to coast, our HITRUST designation is essential to our mission and to the continued growth of our company,” — MedReview Chief Executive Officer, Spencer Young.

MedReview, Inc., a leading provider of payment integrity, utilization management and quality surveillance services, today announced its designation as a HITRUST Authorized External Assessor. With this designation, MedReview is approved to provide services using the HITRUST CSF®, a comprehensive and certifiable framework that addresses a multitude of security, privacy and regulatory challenges facing organizations seeking to comply with healthcare (HIPAA, HITECH), third-party (PCI, COBIT), government (NIST, FTC) and other industry-specific regulations and standards.

Authorized External Assessors such as MedReview are critical to upholding information security and privacy standards for various industries, providing trained resources to assess compliance with security control requirements and document corrective action plans that align with the HITRUST CSF. MedReview serves as a key component of the program by providing assessment and remediation services to healthcare organizations that deal with Protected Health Information (PHI) and/or Personally Identifiable Information (PII).

“As a leading healthcare review organization serving payors from coast to coast, our HITRUST designation is essential to our mission and to the continued growth of our company,” said MedReview Chief Executive Officer, Spencer Young. “I’m very proud to see our entire team rally around this important project to help us better serve the needs of our payor clients who demand the highest levels of assurance.”

The latest release of HITRUST includes several changes based on feedback from the HITRUST community, including miscellaneous corrections, clarification, and enhancement of certain illustrative procedures to ensure alignment with the corresponding authoritative sources, modifications of certain requirement statements and more. These updates reflect HITRUST’s commitment to providing a framework fitting for any organization globally.

MedReview also received HIGHTRUST r2 Certification, the prestigious honor representing the gold standard for information protection assurances based on the comprehensiveness of control requirements, depth of quality review and consistency of oversite. This certification puts MedReview into an elite group of organizations capable of providing the highest levels of security for PHI and PII.

“External Assessors meet rigorous criteria to become qualified, which enables them to be a trusted and independent resource for clients needing to improve their security posture,” said Matthew Datel, Director, Education & Strategic Initiatives at HITRUST. “External Assessors are an integral component to providing qualified third-party reviews for clients seeking HITRUST CSF Certification.”

About MedReview

Headquartered in the financial district of New York City and serving all U.S. states and territories, MedReview has been a leading provider of payment integrity, utilization management and quality surveillance services for more than 40 years. A physician-led organization with a passion for ensuring that health care claims fairly represent the care provided, MedReview provides timely independent hospital billing audits and clinical validation reviews on behalf of health plans, government agencies and Taft-Hartley organizations, saving millions of dollars for its clients each year. https://www.medreview.us/

Share article on social media or email:

US Fertility welcomes Amy Lee Harris, M.D., to the Shady Grove Fertility (SGF) physician team


Dr. Amy Lee Harris is now accepting new patient appointments at SGF Colorado’s Colorado Springs office.

“SGF’s patient-centered approach recognizes that fertility care differs for every patient. I empower my patients to ask questions and advocate for themselves so that they feel confident taking the next steps with me along their fertility journeys.”

US Fertility, the largest, physician-led, integrated network of top-tier fertility practices in the United States, welcomes Amy Lee Harris, M.D., to Shady Grove Fertility’s (SGF) Colorado Springs, Colorado, location. Dr. Harris is now accepting new patient appointments.

“I am honored to join the extraordinary SGF Colorado team that is dedicated to providing world-class fertility care,” shares Dr. Harris. “SGF’s patient-centered approach recognizes that fertility care differs for every patient. I empower my patients to ask questions and advocate for themselves so that they feel confident taking the next steps with me along their fertility journeys.”

Prior to joining SGF, Dr. Harris served as a lieutenant colonel in the United States Air Force, working with patients at Wright Patterson Medical Center on Wright Patterson Air Force Base in Ohio. In addition to providing patient care as a fertility specialist, she held the position of REI Division Director on base as well as an assistant professor in the Department of OB/GYN at the Wright State University Boonshoft School of Medicine.

As an avid researcher, Dr. Harris has contributed to numerous publications, presentations, and book chapters exploring topics such as in vitro fertilization success rates, uterine fibroids, and elective single embryo transfers. Dr. Harris is a member of several professional organizations, including the American Society for Reproductive Medicine (ASRM), the American Congress of Obstetricians and Gynecologists (ACOG), and the American Association of Gynecologic Laparoscopists.    

Dr. Harris will provide comprehensive fertility services, including:


  • fertility and ovarian reserve testing and diagnosis,
  • semen analysis,
  • hysterosalpingogram (HSG),
  • low-tech fertility treatment options such as intrauterine insemination (IUI),
  • in vitro fertilization (IVF),
  • donor egg, sperm, and embryo,
  • genetic screening and testing,
  • gestational carrier,
  • egg freezing,
  • fertility preservation for patients with cancer, and
  • LGBTQ+ family building.

“We’re thrilled to welcome Dr. Harris to the SGF Colorado team,” shares Alex Polotsky, M.D., Medical Director of SGF Colorado. “Dr. Harris brings her commitment to compassionate patient care and dedication to evidence-based medicine, which are core values for SGF.”

Patients may now schedule a new patient appointment with Dr. Harris by calling 720-778-3810 or by submitting this brief form.

About US Fertility

US Fertility is the largest, physician-led, integrated network of top-tier fertility practices in the United States, offering comprehensive fertility-market-focused non-clinical, administrative, and technical platforms that help domestic and international practices improve patient outcomes and increase patient access. To learn more about partnership- or affiliate-status benefits, call 301-545-1308 or visit USFertility.com.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 100,000 babies born from 30+ years of continuous innovation and patient-centered fertility care. With 46 locations, including new locations in Texas, as well as throughout CO, FL, GA, MD, NY, PA, TX, VA, D.C., and Santiago, Chile, SGF offers patients in-person and virtual physician consults, delivers individualized care, accepts most insurance plans, and makes treatment affordable through innovative financial options, including 100% refund guarantees. SGF is among the founding partner practices of US Fertility, the largest physician-led partnership of top-tier fertility practices in the U.S. Call 1-888-761-1967 to schedule a new patient appointment or visit ShadyGroveFertility.com for more information.

Share article on social media or email:

Cummings Graduate Institute for Behavioral Health Studies Earns DEAC Accreditation Renewal


Cummings Graduate Institute for Behavioral Health Studies (CGI) has earned re-accreditation effective July 22, 2022 from the Distance Education Accrediting Commission (DEAC), which is listed by the U.S. Department of Education as a recognized accrediting agency and recognized by the Council for Higher Education Accreditation (CHEA). Accreditation renewal was awarded to CGI for five (5) years, through June 2027, the maximum accreditation time period permitted by DEAC.

Accreditation by DEAC is a reliable indicator of the value and quality of the distance education that an institution offers. In receiving this renewal of accreditation, Cummings Graduate Institute for Behavioral Health Studies has demonstrated its commitment to educational standards and ethical business practices that assure quality, accountability, and improvement in higher education.

The scope of Cummings Graduate Institute for Behavioral Health Studies accreditation

extends to following programs.

Degree Programs


  • Doctor of Behavioral Health
  • Master of Healthcare Leadership

Certificate Programs

  • Trauma-Informed Healthcare Certificate
  • Integrated Behavioral Healthcare Certificate – Adult Specialty
  • Integrated Behavioral Healthcare Certificate – Gerontology Specialty
  • Integrated Behavioral Healthcare Certificate – Military Families and Veterans Specialty
  • Integrated Behavioral Healthcare Certificate – Women’s Health Specialty
  • Integrated Behavioral Healthcare Certificate – Leadership Specialty

About Cummings Graduate Institute for Behavioral Health Studies

Cummings Graduate Institute for Behavioral Health Studies, a private, nonprofit, DEAC accredited institution, offers education and training in integrated behavioral healthcare through a virtual online campus. To learn more about Cummings Graduate Institute for Behavioral Health Studies, visit https://cgi.edu/.

About DEAC

Founded in 1926, the Distance Education Accrediting Commission (DEAC) is a private, non-governmental organization created for the purpose of establishing standards of accreditation and reviewing institutions and programs against these standards. DEAC accreditation is an objective, independent, and reliable validation of an institution’s performance. As of July 2, 2019, 88 degree granting and postsecondary institutions have achieved DEAC accreditation. To learn more about DEAC, visit https://www.deac.org/.

Share article on social media or email:

BestRx Partners with ScriptAbility to Offer Accessible Prescription Labels to Increase Patient Safety and Adherence


BestRx has partnered with ScriptAbility, a company that provides high-tech, accessible pharmacy labels to ensure all patients understand how to take their medications. With this integration, independent pharmacies that use BestRx’s Pharmacy Management Software can quickly generate a variety of accessible labels for their patients with visual and language barriers. This includes ScripTalk RFID-enabled talking labels, ScriptView large print or dual-language labels, Braille labels, and Controlled Substance Safety Labels (CSSL). These accessible labels allow BestRx pharmacies to better care for all of their patients, and ensures that patients with visual or language barriers can easily access their prescription dispensing information too.

BestRx knows how vital dispensing and safety information is to prevent unintentional medication misuse and to the overall success of the treatment. That’s why they decided to integrate their pharmacy software management software with ScriptAbility’s advanced label technology. Thousands of independent pharmacies nationwide utilize BestRx’s user-friendly pharmacy software management software, and with their newest integration, they can feel even more confident they’re providing their patients with the best possible. Plus, the integration makes using accessible labels easy on the pharmacy too. In fact, ScriptAbility’s easy-to-use application can be accessed directly from the BestRx pharmacy management software. Instead of having to re-enter patient information in the application, the patient and prescription details will auto-populate with a few simple clicks.

About BestRx

Founded in 1985, BestRx proud to still be a family business that’s committed to providing independent pharmacies with comprehensive pharmacy management software solutions to become more efficient and profitable. BestRx continues to develop innovative solutuons to insure independent pharmacies have all the tools they need to operate their best and grow their business. BestRx prides itself on its intuitive, easy-to-use platform, robust integrations, and unparalleled customer service. To learn more about BestRx, please visit: http://www.bestrx.com

About En-Vision America/ScriptAbility

Located in Palmetto, Florida, En-Vision America is a company that designs high-tech products aimed at supporting those with visual impairments. With this in mind, En-Vision America created ScriptAbility and its suite of accessible prescription labels. They are proud to offer the most robust, cost-effective accessible label options in the market, including ScripTalk talking prescription labels, ScriptView large print labels, dual-language labels, Braille labels and Controlled Substance Safety Labels (CSSLs). To learn more about ScriptAbility, please visit: http://www.scriptability.com/contact-us.

Share article on social media or email:

Intravenous Acetaminophen Use in Postoperative Pain Management


The PK model was developed using a two-compartment model, and the PD model was developed using a linear model and an effect compartment model.

Anesthesia Progress – As the use of pain management through prescription opioids continues to be a highly debated topic as it relates to developing a substance use disorder, clinicians are looking for less addictive options. Oral acetaminophen use for pain management has been widely accepted as part of a standard medication therapy in postoperative patients; however, the use of intravenous acetaminophen has yet to be thoroughly explored.

To analyze the pharmacokinetic-pharmacodynamic properties of using IV acetaminophen as a postoperative pain medication, researchers from the Showa University School of Dentistry and the Showa University School of Pharmacy in Tokyo, Japan, recently published a randomized, single-blind, crossover design study in the current issue of Anesthesia Progress. This trial sought to examine the timing of administration of IV acetaminophen to reach peak effectiveness for pain management in postoperative patients.

A total of 15 patients, 7 male and 8 female, with an average age of approximately 29 years, were randomized into two groups receiving either IV acetaminophen or placebo (saline). Patients received 1000-mg IV acetaminophen or saline via infusion pump for 15 minutes; vital signs were monitored at 60, 120, and 240 minutes. Pain was measured using the PainVision PS-2100 device and evaluated before IV administration and then at 0, 30, 60, 90, 120, 180, 240, and 300 minutes after.

“The PK model was developed using a two-compartment model, and the PD model was developed using a linear model and an effect compartment model,” according to lead researcher Maho Shinoda, DDS, and colleagues. The PK-PD measurements were based on plasma concentration level from 5-mL blood sample collected before administration at 0, 15, 30, 45, 60, 90, 120, 180, 240, and 300 minutes.

Trial results show a significant difference in pain levels between 90 and 300 minutes in the IV acetaminophen group, indicating that the effective onset of pain relief occurred 90 minutes after administration. The plasma concentration peaked immediately after administration of IV acetaminophen, which suggests a “significant time lag, as high as 180 minutes, was confirmed between the peak plasma concentration and the peak analgesic effect,” writes Shinoda et al.

The American Society of Anesthesiologists guidelines state that “ASA members agree and the consultants strongly agree that acetaminophen should be considered as part of a postoperative multimodal pain management regimen,” yet the use IV acetaminophen has not been thoroughly explored. This research shows that the pain-relieving effect of IV administration begins approximately 90 minutes after and up to 5 hours post acetaminophen infusion, indicating that under the proper time constraints IV acetaminophen can assist in proper pain management of postoperative patients. No adverse effects were experienced by any patients, confirming the efficacy of this therapeutic approach.

Study author, Takehiko Iijima, DDS, PhD, adds “acetaminophen has been recognized to become effective after a considerable interval. No one has made clear how long it takes. Thus, the optimal regimen for how to prescribe acetaminophen has not been determined. Our article has shown that more than two hours are required to achieve the peak of effect site concentration.”

Full text of the article, “Optimal Timing of Intravenous Acetaminophen Administration for Postoperative Analgesia,” Anesthesia Progress, Vol. 69, No. 2, 2022, is now available at https://doi.org/10.2344/anpr-69-02-05 .

###

About Anesthesia Progress

Anesthesia Progress is the official publication of the American Dental Society of Anesthesiology (ADSA). The quarterly journal is dedicated to providing a better understanding of the advances being made in the science of pain and anxiety control in dentistry. The journal invites submissions of review articles, reports on clinical techniques, case reports, and conference summaries. To learn more about the ADSA, visit: http://www.adsahome.org/.

Media Contact:

Samantha Weinkauf

Allen Press, Inc.

785/865-9123

sweinkauf@allenpress.com

Share article on social media or email:

2023 Zeigler Kalamazoo Marathon Registration Opens August 1, Live Kick Off Event At Gazelle Sports


2023 Zeigler Kalamazoo Marathon Registration Opens August 1, Live Kick Off Event At Gazelle Sports

2023 Zeigler Kalamazoo Marathon Registration Opens August 1, Live Kick Off Event At Gazelle Sports

We are excited to kick off the promotion for the 2023 Zeigler Kalamazoo Marathon. We had such a successful event last year, and we know it’ll only be even better this year with us bringing the full marathon back.

Registration for the 2023 Zeigler Kalamazoo Marathon will officially open online at zeiglerkalamazoomarathon.com on August 1, 2022 at 6:00 p.m. The event will be live-streamed by Zeigler’s Driving Vision Podcast at Gazelle Sports, located on the Kalamazoo Mall. The registration kickoff will include photo-ops, giveaways, race information, and swag for the first 50 guests; with an after-event wrap up at Old Burdick’s Bar & Grill.

The 2023 Zeigler Kalamazoo Marathon will be held on April 22 and the 23rd next year and will include a full marathon race for the first time in three years; along with the Kids’ 1K, 5K Run/Walk, 10K, and half marathon.

“We are excited to kick off the promotion for the 2023 Zeigler Kalamazoo Marathon. We had such a successful event last year, and we know it’ll only be even better this year with us bringing the full marathon back,” said Aaron Zeigler, president and CEO of Zeigler Auto Group, the race’s main sponsor.

The Zeigler Kalamazoo Marathon made history earlier this year by announcing its 2023 date on the hood of the Zeigler.com No. 77 NASCAR race car piloted by Spire Motorsports’ Josh Bilicki. This was the first time in history a date for a marathon was revealed to the national and worldwide media this way.

“We are thrilled to kick registration off on August 1 for the 2023 Zeigler Kalamazoo Marathon in anticipation of the return of the full marathon! The entire weekend is dedicated to celebrating health,” said Carrie Drake, race director.

“We want to ensure everyone who wants to be a part of driving a healthy community together has ample time to plan – be it for any of the runs and 5k walk or by volunteering, planning a spirit station, or joining the Saturday and Sunday fun as spectators! Everyone is welcome and everyone can drive a healthy community.”


Event Kickoff: 9:00a.m.

Kids’ 1K: 10:00a.m.

Full Marathon: 7:30am

Half Marathon: 7:35am

5K Walk/Run: 7:55am

10K: 8:00am

The Zeigler Kalamazoo Marathon is currently offering 10% off all registrations with code ZKZMOpen2023. The discount will be effective up to 24 hours after registration opening starting 6:00p.m. August 1, 2022.

About Zeigler Auto Group

Zeigler Automotive Group is one of the largest privately-owned dealer groups in the U.S. with 78 franchises across 35 locations in Wisconsin, Illinois, Indiana, and Michigan. Vehicle brands represented include all of the domestic and the majority of the imported manufacturers.

Besides its extensive automotive portfolio, the organization owns and operates Zeigler Motorsports, an 85,000-square-foot motorsports dealership and action park, offering 19 different powersports brands, plus its own onsite restaurant: Trak Houz Bar & Grill. Additionally, Zeigler Motorsports houses the Elevate Leadership & Team Building Academy, an executive training company.

The Kalamazoo-based dealer group also owns and operates Zeigler Pre-Owned of Chicago, a Carquest Auto Parts store, three Byrider franchises, three finance companies, several insurance firms, and a leasing firm.

Additionall, the dealer group’s new Driving Vision Podcast, hosted by COO Sam D’Arc and Director of Talent Development Mike Van Ryn, invites celebrities, business leaders, and athletes to share their unique perspective on what drives innovation in their careers.

Founded in 1975, the organization employs over 2,300 people, ranking among the top 1% of automotive dealers in the nation with estimated annual sales of $2.2 billion for 2022. The family-owned and operated company is well known for its commitment to both customer service and employee satisfaction. Zeigler is regularly recognized as one of the Best and Brightest Companies to Work for in the Nation, also earning similar accolades in Wisconsin, Chicago, and Michigan.

Share article on social media or email:

Impact Advisors Named to Consulting Magazine’s “Best Large Firms to Work For” List


“We’re proud our focus on creating a positive workplace remains a constant as we continue to grow in size and expand into new service areas for our clients.”

Impact Advisors, a leading healthcare consultancy providing strategy, operations, revenue cycle management, and technology services, was named to Consulting Magazine’s “Best Large Firms to Work For” List, receiving the honor in the Large Firms category for the second year in a row. The firm has previously appeared on the magazine’s “Best Small Firms to Work For” list 11 times since 2009.

“Creating a culture of caring and collaboration is one of our greatest guiding principles and it is reflected every day by our team of passionate professionals,” said Andy Smith, managing partner and founder at Impact Advisors. “We’re proud our focus on creating a positive workplace remains a constant as we continue to grow in size and expand into new service areas for our clients.”

The Best Firms to Work For survey is widely considered to be the most comprehensive, independent source of opinion about the quality of life within the consulting professions’ top firms. Results are based on an annual online survey ranking employee satisfaction in the categories of culture, career development, client engagement, compensation and benefits and firm leadership. This is the 23rd year the publication has ranked the “Best Large Firms.”

“This honor is always especially exciting because it’s based on feedback compiled directly from our associates,” said Michael Nutter, vice president and Happyologist at Impact Advisors. “This prestigious recognition serves as validation that we have stuck to our roots of keeping our culture exceptional and our people happy, and we look forward to celebrating this achievement with our Impact family.”

The firm will be honored during the “Best Firms to Work For” awards ceremony Sept. 15 in Chicago where official rankings will also be announced.

Impact Advisors focuses on culture through a variety of innovative initiatives, including a dedicated Happyologist who concentrates on fostering and maintaining a positive workplace. In addition, coaches are assigned to each associate to help with professional development goals, team members can recognize a colleague for going above and beyond with a “High Impact Award,” and the firm offers unlimited PTO to encourage work-life balance. This year, Impact debuted its Diversity & Inclusion pro bono engagement program as a way to give back to a deserving non-profit advancing diversity and inclusion in the healthcare space.

Impact Advisors adds this honor to a growing list of industry and workplace awards that include being named Best in KLAS for 15 consecutive years, Modern Healthcare’s Best Places to Work list for 13 years and Forbes Best Management Consulting Firms for six consecutive years.

About Impact Advisors

Impact Advisors is a nationally recognized healthcare management consulting and technology services firm that is solving some of the toughest challenges in the industry by delivering strategic advisory, technology implementation and operational improvement services. Our comprehensive suite of strategic planning, digital health, clinical optimization and revenue cycle services spans the lifecycle of our clients’ needs. Our experienced team has a powerful combination of clinical, revenue, operations, consulting and information technology experience. The firm has earned several prestigious industry and workplace awards including Best in KLAS® for 15 consecutive years, Healthcare Informatics HCI 100, Crain’s Chicago Business Fast Fifty, as well as “best place to work” awards from: Modern Healthcare, Consulting Magazine, Becker’s Hospital Review and Achievers. For more information about Impact Advisors, visit http://www.impact-advisors.com.

Share article on social media or email: